Suppr超能文献

免疫调节性耶尔森氏菌外膜蛋白(Yops)——对细菌和人类都有用的工具。

Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

作者信息

Grabowski Benjamin, Schmidt M Alexander, Rüter Christian

机构信息

a Institute of Infectiology - Centre for Molecular Biology of Inflammation (ZMBE), University of Münster , Münster , Germany.

出版信息

Virulence. 2017 Oct 3;8(7):1124-1147. doi: 10.1080/21505594.2017.1303588. Epub 2017 Mar 15.

Abstract

Human-pathogenic Yersinia produce plasmid-encoded Yersinia outer proteins (Yops), which are necessary to down-regulate anti-bacterial responses that constrict bacterial survival in the host. These Yops are effectively translocated directly from the bacterial into the target cell cytosol by the type III secretion system (T3SS). Cell-penetrating peptides (CPPs) in contrast are characterized by their ability to autonomously cross cell membranes and to transport cargo - independent of additional translocation systems. The recent discovery of bacterial cell-penetrating effector proteins (CPEs) - with the prototype being the T3SS effector protein YopM - established a new class of autonomously translocating immunomodulatory proteins. CPEs represent a vast source of potential self-delivering, anti-inflammatory therapeutics. In this review, we give an update on the characteristic features of the plasmid-encoded Yops and, based on recent findings, propose the further development of these proteins for potential therapeutic applications as natural or artificial cell-penetrating forms of Yops might be of value as bacteria-derived biologics.

摘要

人类致病性耶尔森氏菌可产生质粒编码的耶尔森氏菌外膜蛋白(Yops),这些蛋白对于下调限制细菌在宿主体内存活的抗菌反应是必需的。这些Yops可通过III型分泌系统(T3SS)有效地直接从细菌转运至靶细胞胞质溶胶中。相比之下,细胞穿透肽(CPPs)的特征在于其能够自主穿过细胞膜并运输货物,而无需额外的转运系统。最近发现的细菌细胞穿透效应蛋白(CPEs)——以T3SS效应蛋白YopM为原型——确立了一类新的自主转运免疫调节蛋白。CPEs是潜在的自我递送抗炎治疗药物的丰富来源。在本综述中,我们更新了质粒编码Yops的特征,并基于最近的研究结果,提出进一步开发这些蛋白用于潜在治疗应用,因为天然或人工细胞穿透形式的Yops作为细菌衍生的生物制品可能具有价值。

相似文献

1
Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.
Virulence. 2017 Oct 3;8(7):1124-1147. doi: 10.1080/21505594.2017.1303588. Epub 2017 Mar 15.
2
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
Annu Rev Microbiol. 2005;59:69-89. doi: 10.1146/annurev.micro.59.030804.121320.
3
Current activities of the Yersinia effector protein YopM.
Int J Med Microbiol. 2015 May;305(3):424-32. doi: 10.1016/j.ijmm.2015.03.009. Epub 2015 Apr 1.
4
The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.
Mol Microbiol. 1997 Mar;23(5):861-7. doi: 10.1046/j.1365-2958.1997.2731623.x.
5
The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.
Folia Microbiol (Praha). 1998;43(3):253-61. doi: 10.1007/BF02818610.
8
Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM.
Cell Mol Life Sci. 2013 Dec;70(24):4809-23. doi: 10.1007/s00018-013-1413-2. Epub 2013 Jul 9.
9
Modulation of Rho GTPases and the actin cytoskeleton by Yersinia outer proteins (Yops).
Int J Med Microbiol. 2001 Sep;291(4):269-76. doi: 10.1078/1438-4221-00130.
10
Molecular determinants of Yersinia pathogenesis.
Microbiologia. 1996 Jun;12(2):267-80.

引用本文的文献

2
Yersinia pestis Actively Inhibits the Production of Extracellular Vesicles by Human Neutrophils.
J Extracell Vesicles. 2025 Apr;14(4):e70074. doi: 10.1002/jev2.70074.
3
actively inhibits the production of extracellular vesicles by human neutrophils.
bioRxiv. 2024 Dec 21:2024.12.20.629761. doi: 10.1101/2024.12.20.629761.
4
Distinct mechanisms of type 3 secretion system recognition control LTB4 synthesis in neutrophils and macrophages.
PLoS Pathog. 2024 Oct 18;20(10):e1012651. doi: 10.1371/journal.ppat.1012651. eCollection 2024 Oct.
6
Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.
Front Immunol. 2024 May 21;15:1397579. doi: 10.3389/fimmu.2024.1397579. eCollection 2024.
7
9
Yersinia enterocolitica in Crohn's disease.
Front Cell Infect Microbiol. 2023 Mar 8;13:1129996. doi: 10.3389/fcimb.2023.1129996. eCollection 2023.
10
Immune evasion and persistence in enteric bacterial pathogens.
Gut Microbes. 2023 Jan-Dec;15(1):2163839. doi: 10.1080/19490976.2022.2163839.

本文引用的文献

1
The Amino-Terminal Part of the Needle-Tip Translocator LcrV of Is Required for Early Targeting of YopH and Virulence.
Front Cell Infect Microbiol. 2016 Dec 5;6:175. doi: 10.3389/fcimb.2016.00175. eCollection 2016.
3
Yersinia YopJ negatively regulates IRF3-mediated antibacterial response through disruption of STING-mediated cytosolic DNA signaling.
Biochim Biophys Acta. 2016 Dec;1863(12):3148-3159. doi: 10.1016/j.bbamcr.2016.10.004. Epub 2016 Oct 11.
4
Cell-Penetrating Bacterial Effector Proteins: Better Tools than Targets.
Trends Biotechnol. 2017 Feb;35(2):109-120. doi: 10.1016/j.tibtech.2016.08.002. Epub 2016 Sep 1.
5
The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.
Cell Host Microbe. 2016 Sep 14;20(3):296-306. doi: 10.1016/j.chom.2016.07.018. Epub 2016 Aug 25.
7
Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family.
Nat Struct Mol Biol. 2016 Sep;23(9):847-52. doi: 10.1038/nsmb.3279. Epub 2016 Aug 15.
8
The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases.
Mol Cell. 2016 Jul 21;63(2):261-276. doi: 10.1016/j.molcel.2016.06.015. Epub 2016 Jul 14.
9
Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells.
PLoS Pathog. 2016 Jun 14;12(6):e1005660. doi: 10.1371/journal.ppat.1005660. eCollection 2016 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验